Datadog (DDOG) Stock Forecast & Price Target

$157.95 +1.04 (+0.66%)

(As of 09:40 AM ET)

Datadog - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 30 Analyst Ratings

Sell
1

Hold
1

Buy
28

Based on 30 Wall Street analysts who have issued ratings for Datadog in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 30 analysts, 1 has given a sell rating, 1 has given a hold rating, 26 have given a buy rating, and 2 have given a strong buy rating for DDOG.

Consensus Price Target

$155.07
-1.82% Downside

According to the 30 analysts' twelve-month price targets for Datadog, the average price target is $155.07. The highest price target for DDOG is $200.00, while the lowest price target for DDOG is $133.00. The average price target represents a forecasted downside of -1.82% from the current price of $157.95.

Get the Latest News and Ratings for DDOG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Datadog and its competitors.

DDOG Analyst Ratings Over Time

Type	Current Forecast 12/19/23 to 12/18/24	1 Month Ago 11/19/23 to 11/18/24	3 Months Ago 9/20/23 to 9/19/24	1 Year Ago 12/19/22 to 12/19/23
Strong Buy	2 Strong Buy rating(s)	2 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	26 Buy rating(s)	25 Buy rating(s)	25 Buy rating(s)	23 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	4 Hold rating(s)	7 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$155.07	$150.96	$139.88	$112.45
Forecasted Upside	-1.82% Downside	19.84% Upside	21.09% Upside	-8.14% Downside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Vacuum up cash with these special trades? (Ad)

Have you ever heard about a “volatility vacuum?” Most people haven’t. It all revolves around this formula right here. Now, the most important thing is that this equation — when applied to certain tickers at a certain time each month —- can trigger these “volatility vacuums.” And when that happens, anyone has the shot at sucking out payouts of $290, $350, even $1,350 in as little as 24 hours. (With just a $1k starting stake!) Granted, there were smaller wins and those that did not work out but best of all, we can know exactly when these opportunities will hit. I’ve used this info to create a Cash Calendar that lays out the precise dates of these payouts.

And I’m sending it for FREE to anyone who joins me during my FREE training right here.

DDOG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

DDOG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Datadog Stock vs. The Competition

Type	Datadog	Computer and Technology Companies	S&P 500
Consensus Rating Score	2.97	2.68	2.51
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	-1.17% Downside	265.65% Upside	12.03% Upside
News Sentiment Rating	Positive News See Recent DDOG News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/13/2024	Mizuho 2 of 5 stars	G. Moskowitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$155.00 ➝ $170.00	+8.47%
12/12/2024	Truist Financial 2 of 5 stars		Boost Target	Buy ➝ Buy	$155.00 ➝ $170.00	+9.16%
12/12/2024	Macquarie 1 of 5 stars	C. Beynon Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Hold ➝ Outperform	$200.00	+27.81%
12/6/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$155.00 ➝ $187.00	+12.34%
11/19/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$165.00 ➝ $165.00	+27.90%
11/8/2024	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$140.00 ➝ $148.00	+18.92%
Healthcare Takes A Big Step Forward With The Help of A.I. (Ad) To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare. Click here to learn more about the booming eHealth industry - and see which microcap will be at the
11/8/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$150.00 ➝ $157.00	+26.12%
11/8/2024	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Luria Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$140.00 ➝ $150.00	+21.51%
11/8/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$135.00 ➝ $145.00	+11.72%
11/8/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$140.00 ➝ $150.00	+15.57%
11/8/2024	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Sector Outperform ➝ Sector Outperform	$135.00 ➝ $133.00	+2.47%
11/7/2024	Monness Crespi & Hardt Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. White Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$155.00	+19.40%
10/21/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$157.00 ➝ $151.00	+19.54%
10/18/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Underperform ➝ Underperform
10/17/2024	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Ives Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Buy ➝ Strong-Buy
10/8/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Degasperi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$150.00	+22.57%
8/9/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$151.00 ➝ $151.00	+34.69%
8/9/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$165.00 ➝ $140.00	+22.74%
8/1/2024	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Powell Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$143.00	+22.81%
7/22/2024	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Y. Lee Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$150.00 ➝ $150.00	+23.10%
7/15/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Materne Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$150.00	+17.37%
7/5/2024	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Y. Kim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$160.00 ➝ $160.00	+21.67%
5/30/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$143.00 ➝ $155.00	+27.38%
5/8/2024	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Walravens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
5/8/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	W. Power Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
4/23/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Equal Weight ➝ Overweight	$130.00 ➝ $150.00	+22.88%
4/22/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$152.00	+25.53%
2/23/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$150.00	+13.78%
2/16/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform
2/14/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$140.00 ➝ $150.00	+11.31%
11/8/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$100.00 ➝ $110.00	+10.01%
11/8/2023	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$95.00 ➝ $115.00	+12.52%
11/7/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Overweight	$90.00 ➝ $115.00	+12.52%
10/23/2023	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral
10/2/2023	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Overweight	$88.00 ➝ $115.00	+26.25%
8/9/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$125.00	+44.08%
8/9/2023	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$120.00	+38.31%
5/4/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$85.00 ➝ $90.00	+19.36%
2/17/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy	$128.00 ➝ $114.00	+42.52%
2/17/2023	Capital One Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$105.00	+27.32%
Healthcare Takes A Big Step Forward With The Help of A.I. (Ad) To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare. Click here to learn more about the booming eHealth industry - and see which microcap will be at the

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 10:02 AM ET.

Should I Buy Datadog Stock? DDOG Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, December 13, 2024. Please send any questions or comments about these Datadog pros and cons to contact@marketbeat.com.

Datadog
Bull Case

Here are some ways that investors could benefit from investing in Datadog, Inc.:

Datadog, Inc. has shown strong institutional interest, with 78.29% of its stock owned by institutional investors, indicating confidence in the company's future performance.
The stock is currently trading at $157.24, which is significantly above its 1-year low of $98.80, suggesting a positive trend in its market performance.
Recent analyst ratings have been favorable, with 26 analysts giving a buy rating and a target price averaging $155.07, indicating potential for price appreciation.
Datadog, Inc. operates in the growing field of observability and security for cloud applications, positioning itself well in a market that is increasingly reliant on cloud technology.
The company has a robust market capitalization of $57.29 billion, reflecting its strong position and stability in the tech sector.

Datadog
Bear Case

Investors should be bearish about investing in Datadog, Inc. for these reasons:

The P/E ratio is quite high at 318.21, which may indicate that the stock is overvalued compared to its earnings, potentially leading to a price correction.
There has been a significant increase in short interest, growing by 40.9% recently, which may suggest that investors are betting against the stock's performance.
Insider selling has been notable, with insiders selling a total of 543,979 shares worth $69,320,699 in the last 90 days, which could signal a lack of confidence in the company's near-term prospects.
The company's beta of 1.11 indicates that its stock price is more volatile than the market, which could pose risks for investors looking for stability.
Despite a strong market presence, the competitive landscape in the observability and security sector is intense, which could impact Datadog, Inc.'s market share and growth potential.

DDOG Forecast - Frequently Asked Questions

: According to the research reports of 30 Wall Street equities research analysts, the average twelve-month stock price forecast for Datadog is $155.07, with a high forecast of $200.00 and a low forecast of $133.00.
: 30 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Datadog in the last twelve months. There is currently 1 sell rating, 1 hold rating, 26 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" DDOG shares.
: According to analysts, Datadog's stock has a predicted downside of -1.82% based on their 12-month stock forecasts.
: Over the previous 90 days, Datadog's stock had 4 upgrades by analysts.
: Datadog has been rated by research analysts at Barclays, BMO Capital Markets, BNP Paribas, Citigroup, DA Davidson, Macquarie, Mizuho, Monness Crespi & Hardt, Robert W. Baird, Rosenblatt Securities, Sanford C. Bernstein, Scotiabank, TD Cowen, Truist Financial, UBS Group, and Wedbush in the past 90 days.
: Analysts like Datadog more than other "computer and technology" companies. The consensus rating score for Datadog is 2.97 while the average consensus rating score for "computer and technology" companies is 2.68. Learn more on how DDOG compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

How this >10-cent coin is going to outperform Bitcoin (Ad)

Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career…

#1 FREE Crypto for 2024

This page (NASDAQ:DDOG) was last updated on 12/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Datadog (DDOG) Stock Forecast & Price Target